Both in Pharmaceuticals
TG Therapeutics vs Protagonist Therapeutics
Over the past year TGTX returned +52.6% and PTGX returned +116.4%; their daily moves had a correlation of 0.24.
TGTX +52.6% PTGX +116.4%Growth of $1, one year, split-adjusted
| Metric | TGTX | PTGX |
|---|---|---|
| Price | $56.19 | $140.97 |
| Market cap | $8.60B | $9.12B |
| Today | 0.00% | −1.03% |
| 1 month | +4.2% | −2.3% |
| 6 months | +78.3% | +41.2% |
| Year to date | +88.5% | +61.4% |
| 1 year | +58.3% | +109.1% |
| Revenue growth (YoY) | +70.3% | +3749.2% |
| Gross margin | 82.9% | 100.0% |
| Net margin | 3.2% | 76.3% |
| P/E (TTM) | 19.5× | 110.0× |
| Price / sales | 10.8× | 32.3× |
| Net cash | -$193.1M | $782.6M |
| Dividend yield | — | — |
| Volatility (60d) | 45.9% | 40.1% |
| Short % of float | 20.5% | 13.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).